New patients’ enrollment with Casimersen and Eteplirsen orphan medicine in Kazakhstan.

Therapies of Casimersen and Eteplirsen were initiated for 2 new patients in regions in Kazakhstan.
#rarediseasecompanykazakhstan #businessdevelopmentinkazakhstan #CentralAsia #SareptaTherapeutics #orphandiseasepatientsinKazakhstan #orphanpharmaceuticalcompanyinKazakhstan #rarediseasepatientsinCentralAsia #orphanpharmacompany